Slide 1First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their…
1. HERCEPTIN INDUCEDCARDIOTOXICITYDr. Boaz Vincent 2. MANAGEMENT OF CARDIAC HEALTH IN TRASTUZUMAB-TREATEDPATIENTSWITH BREAST CANCER: UPDATED UNITED KINGDOMNATIONAL CANCERRESEARCH…
1. BOOK BY 31ST MARCH AND SAVE £300 BOOK BY 30TH APRIL AND SAVE £100“Great conference! Well organised” Sanofi30TH JUNE -1ST JULYSMi present their 9th annual conference…
INTRODUCTION: Drugs interacting with the hERG potassium channel are associated with a prolongation of the QT interval, which can lead to life-threatening arrhythmias and…
Slide 1Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast cancer: evidence from the LITE randomized study Giuseppe Biondi Zoccai,…
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall P et al. Proc SABCS…
Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast cancer: evidence from the LITE randomized study Giuseppe Biondi Zoccai, MD University…